MK

Manjeet Kaur

Active Director Director DIN 08549388
DIN 08549388 First appointment Aug 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Manjeet Kaur

Data last updated:

Manjeet Kaur is a Director at Geo Vet Pharma Private Limited (since 2019). The company operates in Trading. Geo Vet Pharma Private Limited reported revenue of ₹14.4 Lakh (FY 2024).

DIN 08549388
Primary Designation Director
Industry Trading
First Appointment 29 Aug 2019
Oldest Company Age 11 yrs
Largest company Geo Vet Pharma Private Limited · ₹14.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Geo Vet Pharma Private Limited U24100HR2015PTC056416
Director29 Aug 20192015₹14.4 Lakh (FY 2024)Active

Board colleagues of Manjeet Kaur

NameDINCompanyDesignation
Ravinder Pal07246820Geo Vet Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Geo Vet Pharma Private Limited
Premium access

Shareholding and investment profile for Manjeet Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjeet Kaur

Manjeet Kaur currently holds 1 directorship: Geo Vet Pharma Private Limited (Director, since 29 Aug 2019, revenue ₹14.4 Lakh (FY 2024)).

Manjeet Kaur was first appointed on 29 Aug 2019 as Director at Geo Vet Pharma Private Limited.

The current boards of Manjeet Kaur's companies include Ravinder Pal (Geo Vet Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available